128 related articles for article (PubMed ID: 26858756)
21. Preoperative serum C-reactive protein and its prognostic significance in patients with stage III-IV colorectal cancer.
Lumachi F; Basso SM; Santeufemia DA; Ermani M; Lo Re G; Chiara GB
Anticancer Res; 2014 Dec; 34(12):7263-6. PubMed ID: 25503158
[TBL] [Abstract][Full Text] [Related]
22. [Predictive value of preoperative detection of CEA and CA199 for prognosis in patients with stage II-III colorectal cancer].
Chen L; Jiang B; Di J; Zhang C; Wang Z; Zhang N; Xing J; Cui M; Yang H; Yao Z; Su X
Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Sep; 18(9):914-9. PubMed ID: 26404690
[TBL] [Abstract][Full Text] [Related]
23. Validation of Prognosis Value of Cumulative Prognostic Scores Based on Serum High-Density Lipoprotein Cholesterol and Albumin Levels in Patients with Colorectal Cancer.
Huang H; Zhang L; Chen DB; Yu XG; He XH; Liu M; Chen PS
J Cancer; 2019; 10(1):35-42. PubMed ID: 30662523
[No Abstract] [Full Text] [Related]
24. Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer.
Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Shibuya N; Kubota K
Ann Surg Oncol; 2016 Mar; 23(3):900-7. PubMed ID: 26530445
[TBL] [Abstract][Full Text] [Related]
25. Preoperative Low Creatine Kinase as a Poor Prognostic Factor in Patients with Colorectal Cancer.
Ushigome M; Shimada H; Kaneko T; Miura Y; Yoshida K; Suzuki T; Kagami S; Kurihara A; Funahashi K
J Gastrointest Cancer; 2024 Jun; ():. PubMed ID: 38869820
[TBL] [Abstract][Full Text] [Related]
26. Preoperative serum carcinoembryonic antigen, carbohydrate antigen19-9 and carbohydrate antigen 125 as prognostic factors for recurrence-free survival in colorectal cancer.
Yang XQ; Chen C; Wang FB; Peng CW; Li Y
Asian Pac J Cancer Prev; 2011; 12(5):1251-6. PubMed ID: 21875276
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of preoperative carcinoembryonic antigen/tumor size in rectal cancer.
Cai D; Huang ZH; Yu HC; Wang XL; Bai LL; Tang GN; Peng SY; Li YJ; Huang MJ; Cao GW; Wang JP; Luo YX
World J Gastroenterol; 2019 Sep; 25(33):4945-4958. PubMed ID: 31543685
[TBL] [Abstract][Full Text] [Related]
28. High serum levels of interleukin-6 in patients with advanced or metastatic colorectal cancer: the effect on the outcome and the response to chemotherapy plus bevacizumab.
Hara M; Nagasaki T; Shiga K; Takahashi H; Takeyama H
Surg Today; 2017 Apr; 47(4):483-489. PubMed ID: 27549777
[TBL] [Abstract][Full Text] [Related]
29. The preoperative platelet to lymphocyte ratio is a prognostic marker in patients with stage II colorectal cancer.
Ozawa T; Ishihara S; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Hata K; Kawai K; Nozawa H; Kazama S; Yamaguchi H; Sunami E; Kitayama J; Watanabe T
Int J Colorectal Dis; 2015 Sep; 30(9):1165-71. PubMed ID: 26049902
[TBL] [Abstract][Full Text] [Related]
30. Elevated preoperative serum C-reactive protein levels are associated with poor survival in patients with colorectal cancer.
Shibutani M; Maeda K; Nagahara H; Ohtani H; Sugano K; Ikeya T; Kimura K; Amano R; Kubo N; Tanaka H; Muguruma K; Ohira M; Hirakawa K
Hepatogastroenterology; 2014; 61(136):2236-40. PubMed ID: 25699359
[TBL] [Abstract][Full Text] [Related]
31. Serum interleukin-6 levels reflect the disease status of colorectal cancer.
Chung YC; Chang YF
J Surg Oncol; 2003 Aug; 83(4):222-6. PubMed ID: 12884234
[TBL] [Abstract][Full Text] [Related]
32. The difference in prognosis of stage II and III colorectal cancer based on preoperative serum tumor markers.
You W; Sheng N; Yan L; Chen H; Gong J; He Z; Zheng K; Chen Z; Wang Y; Tan G; Xie L; Wang Z
J Cancer; 2019; 10(16):3757-3766. PubMed ID: 31333793
[No Abstract] [Full Text] [Related]
33. Stromal Expression of Vimentin Predicts the Clinical Outcome of Stage II Colorectal Cancer for High-Risk Patients.
Liu LG; Yan XB; Xie RT; Jin ZM; Yang Y
Med Sci Monit; 2017 Jun; 23():2897-2905. PubMed ID: 28611349
[TBL] [Abstract][Full Text] [Related]
34. High pretreatment serum CA19-9 level predicts a poor prognosis for patients with stage III colon cancer after curative resection and adjuvant chemotherapy.
Zhou W; Yang F; Peng J; Wang F; Lin Y; Jiang W; Yang X; Li L; Lu Z; Wan D; Pan Z; Fan W
J Cancer; 2019; 10(16):3810-3818. PubMed ID: 31333798
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of preoperative prognostic nutritional index and its associations with systemic inflammatory response markers in patients with stage III colon cancer.
Peng J; Zhang R; Zhao Y; Wu X; Chen G; Wan D; Lu Z; Pan Z
Chin J Cancer; 2017 Dec; 36(1):96. PubMed ID: 29268783
[TBL] [Abstract][Full Text] [Related]
36. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
[TBL] [Abstract][Full Text] [Related]
37. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.
Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J
BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242
[TBL] [Abstract][Full Text] [Related]
38. The Association of Simultaneous Increase in Interleukin-6, C Reactive Protein, and Matrix Metalloproteinase-9 Serum Levels with Increasing Stages of Colorectal Cancer.
Rasic I; Rebic V; Rasic A; Aksamija G; Radovic S
J Oncol; 2018; 2018():2830503. PubMed ID: 30154846
[TBL] [Abstract][Full Text] [Related]
39. Intrahepatic cholangiocarcinoma prognostic determination using pre-operative serum C-reactive protein levels.
Lin ZY; Liang ZX; Zhuang PL; Chen JW; Cao Y; Yan LX; Yun JP; Xie D; Cai MY
BMC Cancer; 2016 Oct; 16(1):792. PubMed ID: 27733196
[TBL] [Abstract][Full Text] [Related]
40. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
